Actinic Keratosis (AK) Market 2017- Competitive Landscape, Insights, Epidemiology and Forecast by 2025

Actinic Keratosis Market adds “Actinic Keratosis Market 2017 Global Analysis, Growth, Opportunities Research Report Forecasting to 2025”reports to its database.

PUNE, INDIA, September 11, 2017 / -- Actinic Keratosis Market:

Executive Summary

DelveInsight's "Actinic Keratosis - Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2025"report provides the comprehensive insights on the competitive landscape and market of Actinic Keratosis (AK).

The Report covers an overview of the disease and global market trends of the Actinic Keratosis for the seven major markets i.e., United States, Europe (France, Germany, Italy, Spain, and UK) and Japan. The Report covers the therapeutics market revenue, treatment practice/algorithm and forecasted market size of Actinic Keratosis from 2017 to 2025 segmented by seven major markets. The market size covered in our report is based only upon the topical therapies approved for Actinic Keratosis which represents around 5% of the total market size of Actinic Keratosis.

In addition, the report also includes global forecast of epidemiology of Actinic Keratosis till 2025.The Report also covers market drivers, market barriers and unmet medical need.

The competitive landscape of the report covers both pipeline and marketed portfolio of the indication. Actinic Keratosis pipeline provides information on the therapeutic drugs in development and comparative analysis at various stages covering clinical and pre-clinical & discovery stages, therapeutics assessment by Monotherapy/ Combination products and Molecule Type drug analysis. It also provides in-depth analysis on the Phase III profile covering clinical trial studies, recent developments and SWOT Analysis.

United States accounts for the highest number of prevalent cases of Actinic Keratosis as compared to EU5 and Japan. As per DelveInsight forecasts, 76,603,272 cases of Actinic Keratosis were prevalent in the United States in the year 2015. This number is expected to grow at a CAGR of XX% from 2015 to 2025.

Request Sample Report @

The Topical Therapy of Actinic Keratosis considered in our report include Ingenol mebutate, Diclofenac 3%, Imiquimod 5%, 5-Fluorouracil 5%, Imiquimod 3.75% and Fluorouracil/Salicylic acid combination. Patient adherence is generally low, around 50%-55% when it comes to topical treatment. High percentage of non-adherence to the regimen has been observed amongst the patients opting for topical therapy owing to the long treatment duration. The procedural therapy still remains the standard of care.

United States contributes the major share of the Actinic keratosis(AK) market as compared to EU5 countries and Japan. According to DelveInsight estimation, the market size of Actinic Keratosis (topical therapies only) in the United States, was estimated to be USD 102.62 Millions in 2015 and is expected to grow at a CAGR of XX% from 2015 to 2025.


Overview of the Global pipeline scenario for Actinic Keratosis, products and associated companies information

Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities

Organize sales and marketing efforts by identifying the best opportunities for Actinic Keratosis in US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.

To understand the future market competition in the global Actinic Keratosis market and Insightful review of the key market drivers and barriers.

The report will help in developing business strategies by understanding the trends shaping and driving the global Actinic Keratosis market.

Key topics covered include strategic competitor assessment, barriers and drivers in the market along with SWOT analysis

The Report also covers the detailed global historical and forecasted Actinic Keratosis market covering United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan from 2015-2025.


Buy this Report @

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here